ustekinumab(Stelara)
Anti-IL-12/IL-23 (p40 subunit) monoclonal antibody
Pronunciation
/ʌstɛˈkɪnʊmæb/
International Phonetic Alphabet (IPA). Say it aloud once — you will remember it forever.
At a glance
- Generic name
- ustekinumab
- Brand names
- Stelara
- Therapeutic class
- Anti-IL-12/IL-23 (p40 subunit) monoclonal antibody
- Mechanism (summary)
- <!-- AI-DRAFTED: 2026-06-24 -->
Clinical pearls
- SC self-administration after training (or IV induction for IBD).
- Q12-week maintenance dosing is patient-friendly.
- Screen for latent TB before therapy.
- Report unexplained vision changes, severe headache (RPLS).
- No live vaccines.
Sources
See how ustekinumab appears in NAPLEX-style questions
PharmDHub Premium includes a full drug card, dosing, boxed warnings, drug-drug interactions, and practice questions built around this drug.